Healthcare provider profile · identity verified

Robert Justin Duprey, FNP

Nurse Practitioner · DANVILLE, IL · NPI 1891290839

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	304	68
Amlodipine Besylate	Amlodipine Besylate	258	52
Gabapentin	Gabapentin	216	34
Levothyroxine Sodium	Levothyroxine Sodium	185	32
Torsemide	Torsemide	160	30
Trazodone Hcl	Trazodone Hcl	157	25
Lisinopril	Lisinopril	151	34
Potassium Chloride	Potassium Chloride	139	27
Montelukast Sodium	Montelukast Sodium	136	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	118	26
Cephalexin	Cephalexin	110	75
Metoprolol Succinate	Metoprolol Succinate	110	15
Pantoprazole Sodium	Pantoprazole Sodium	109	24
Losartan Potassium	Losartan Potassium	107	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	104	22
Omeprazole	Omeprazole	103	25
Prednisone	Prednisone	79	45
Tamsulosin Hcl	Tamsulosin Hcl	79	18
Fluticasone Propionate	Fluticasone Propionate	78	26
Mirtazapine	Mirtazapine	78	19
Eliquis	Apixaban	75	18
Sertraline Hcl	Sertraline Hcl	74	18
Buspirone Hcl	Buspirone Hcl	72	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	69	17
Metformin Hcl	Metformin Hcl	68	16
Pregabalin	Pregabalin	62	12
Furosemide	Furosemide	61	16
Escitalopram Oxalate	Escitalopram Oxalate	59	14
Meloxicam	Meloxicam	59	23
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	59	42
Carvedilol	Carvedilol	58	12
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	56	17
Tramadol Hcl	Tramadol Hcl	56	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	55	38
Famotidine	Famotidine	54	12
Clotrimazole	Clotrimazole	51	19
Hydrochlorothiazide	Hydrochlorothiazide	51	13
Jardiance	Empagliflozin	49	13
Metoprolol Tartrate	Metoprolol Tartrate	49	12
Nystatin	Nystatin	49	16
Ropinirole Hcl	Ropinirole Hcl	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	43	32
Levetiracetam	Levetiracetam	42	suppressed
Glipizide	Glipizide	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Latanoprost	Latanoprost	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Donepezil Hcl	Donepezil Hcl	38	13
Divalproex Sodium	Divalproex Sodium	37	suppressed
Fluconazole	Fluconazole	37	22
Memantine Hcl	Memantine Hcl	36	suppressed
Trulicity	Dulaglutide	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Spironolactone	Spironolactone	35	11
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Ozempic	Semaglutide	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	22
Primidone	Primidone	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Humalog Kwikpen U-100	Insulin Lispro	30	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	29	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	28	12
Baclofen	Baclofen	28	suppressed
Loperamide	Loperamide Hcl	28	19
Propranolol Hcl	Propranolol Hcl	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Terbinafine Hcl	Terbinafine Hcl	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	16
Mupirocin	Mupirocin	25	12
Myrbetriq	Mirabegron	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	11
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Ondansetron Odt	Ondansetron	24	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	18	suppressed
Azithromycin	Azithromycin	17	15
Chlorthalidone	Chlorthalidone	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Methimazole	Methimazole	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Risperidone	Risperidone	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Atenolol	Atenolol	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Leflunomide	Leflunomide	14	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Gemtesa	Vibegron	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	12
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error